MetaCap

Mettler-Toledo International Financial Ratios

NYSE: MTDIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD

1,549.99+20.53 (+1.34%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Mettler-Toledo International ratio analysis

Mettler-Toledo International earned a net margin of 21.6% in FY 2025, down from 22.3% a year earlier. Gross margin was 59.4% compared with a median of 58.4% over the prior 9 years. At the end of FY 2025, MTD traded at 33.6 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 24.4 to 51.8, with a median of 34.5.

Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Mettler-Toledo International financial ratios (annual)

Mettler-Toledo International annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2013
P/E ratio (at fiscal year end)33.5630.5933.7937.6351.7845.7535.1426.5243.5124.37
Price / sales7.226.797.008.2910.568.826.454.535.853.06
Price / book———1,311.29229.0096.2946.1022.5329.117.77
Gross margin59.4%60.1%59.2%58.9%58.4%58.4%57.9%57.4%57.8%53.9%
Net margin21.6%22.3%20.8%22.3%20.7%19.5%18.6%17.5%13.8%12.9%
Free cash flow margin21.1%22.3%22.7%18.8%21.6%20.5%16.8%14.4%14.3%11.1%
Return on equity (ROE)———3,519.1%448.6%213.2%133.3%86.9%68.7%32.7%
Return on assets (ROA)23.4%26.6%23.5%25.0%23.1%21.4%20.1%19.6%14.7%14.2%
Debt / equity———81.259.814.723.071.751.790.42
Current ratio1.141.021.041.201.111.261.471.421.461.62
Revenue growth4.0%2.2%-3.4%5.4%20.5%2.5%2.5%7.7%14.5%1.6%
EPS growth3.9%12.8%-6.5%17.2%31.6%10.9%13.0%39.6%43.0%9.0%

Related